These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 940540)

  • 21. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 22. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of formation of fibrin oligomers. III. Ligation kinetics concurrent with and subsequent to oligomer assembly.
    Bale MD; Janmey PA; Ferry JD; Lorand L
    Biopolymers; 1984 Jan; 23(1):127-38. PubMed ID: 6141816
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 29. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of ascorbate and histidine in fibrinogen protection against changes following exposure to a sterilizing dose of gamma-irradiation.
    Zbikowska HM; Nowak P; Wachowicz B
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):669-76. PubMed ID: 17890955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disseminated intravascular coagulation].
    Maekawa T
    Rinsho Byori; 1973 Jan; 21(1):24-30. PubMed ID: 4267649
    [No Abstract]   [Full Text] [Related]  

  • 33. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII.
    Shafer JA; Lewis SD; Janus TJ; Lorand L
    Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-linking of actin and fibrin by fibrin-stabilizing factor.
    Mui PT; Ganguly P
    Am J Physiol; 1977 Sep; 233(3):H346-9. PubMed ID: 910923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis.
    Kłoczko J; Wojtukiewicz M; Bielawiec M; Zuch A
    Thromb Res; 1988 Sep; 51(6):575-81. PubMed ID: 3187967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of factor XIIIa generation by fibrinogen.
    Curtis CG; Janus TJ; Credo RB; Lorand L
    Ann N Y Acad Sci; 1983 Jun; 408():567-76. PubMed ID: 6135381
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction between FXIII and fibrinogen.
    Kohler HP
    Blood; 2013 Mar; 121(11):1931-2. PubMed ID: 23493770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+-related regulatory function of fibrinogen.
    Credo RB; Curtis CG; Lorand L
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4234-7. PubMed ID: 279911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen.
    Marchi R; Carvajal Z; Weisel JW
    Thromb Haemost; 2008 Feb; 99(2):451-2. PubMed ID: 18278201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.